Sue Chua

Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole–body magnetic resonance imaging in radio-recurrent prostate cancer

Shonit Punwani, Taimur T. Shah, Hashim Uddin Ahmed, 2019, BMC Medical Imaging.

Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients

Eric O. Aboagye, Andrew Scarsbrook, Sue Chua, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)

Sue Chua, C. Parker, G. Cook, 2011, EJNMMI research.

Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis.

Vicky Goh, Paul Bassett, Sue Chua, 2015, Radiology.

PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma

John Dickson, Sue Chua, Ashley M. Groves, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.

Sue Chua, Alex Pearson, James Campbell, 2016, Cancer discovery.